Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nga Ching Wo
Observed names:
N C Wo,
N. C. Wo,
N.C. WO,
N.C. Wo,
Ng Ching Wo,
Nga C. Wo,
Nga Wo
show all 7
Institutions:
Cornell University,
Weill Cornell Medicine
Observed institutions:
Centre National de la Recherche Scientifique,
Inserm,
Université de Montpellier,
Cornell University,
Institut Cochin,
Institut de Génomique Fonctionnelle,
Weill Cornell Medicine,
Columbia University,
University of Toledo
show all 9
OpenAlex ID:
A5110119946
Design and synthesis of highly selectivein vitroandin vivouterine receptor antagonists of oxytocin: comparisons with Atosiban
1995
·
M. MANNING
, K. MITEVA
, et al.
·
International journal of peptide & protein research
·
97
No requirement of cyclic conformation of antagonists in binding to vasopressin receptors
1987
·
M. Manning
, J. P. Przybylski
, et al.
·
Nature
·
78
[1-Deamino-4-Cyclohexylalanine] Arginine Vasopressin: A Potent and Specific Agonist for Vasopressin V1b Receptors
2002
·
S. Derick
, L. L. Cheng
, et al.
·
Endocrinology
·
76
Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays
2000
·
W. Y. Chan
, Nga Ching Wo
, et al.
·
Experimental Physiology
·
41
Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin
1990
·
Maurice Manning
, Stoytcho Stoev
, et al.
·
Journal of Medicinal Chemistry
·
40
Design of Oxytocin Antagonists, which are more Selective than Atosiban
2001
·
Maurice Manning
, Stoytcho Stoev
, et al.
·
Journal of Peptide Science
·
38
Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin
1992
·
Maurice Manning
, Stoytcho Stoev
, et al.
·
Journal of Medicinal Chemistry
·
38
Pharmacological and Physiological Characterization of d[Leu4, Lys8]Vasopressin, the First V1b-Selective Agonist for Rat Vasopressin/Oxytocin Receptors
2007
·
Ana Pena
, Brigitte Murat
, et al.
·
Endocrinology
·
37
Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
1996
·
W Y Chan
, N C Wo
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
35
Design and Synthesis of the First Selective Agonists for the Rat Vasopressin V 1b Receptor: Based on Modifications of Deamino-[Cys]arginine Vasopressin at Positions 4 and 8
2007
·
Ana Pena
, Brigitte Murat
, et al.
·
Journal of Medicinal Chemistry
·
31
Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban
2005
·
Maurice Manning
, Ling Ling Cheng
, et al.
·
Journal of Peptide Science
·
31
The role of oxytocin receptors and vasopressin V1a receptors in uterine contractions in rats: Implications for tocolytic therapy with oxytocin antagonists
1996
·
W.Y. Chan
, Ng Ching Wo
, et al.
·
American Journal of Obstetrics and Gynecology
·
31
Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressin
1988
·
M. MANNING
, W.A. KLIS
, et al.
·
International journal of peptide & protein research
·
25
Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors
1997
·
Youssef Ala
, Denis Morin
, et al.
·
European Journal of Pharmacology
·
23
PDF
Position Three in Vasopressin Antagonist Tolerates Conformationally Restricted and Aromatic Amino Acid Substitutions: A Striking Contrast with Vasopressin Agonists
1997
·
Maurice Manning
, Ling Ling Cheng
, et al.
·
Journal of Peptide Science
·
22
An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids
1999
·
S. Stoev
, L.L. Cheng
, et al.
·
Journal of Peptide Science
·
18
An exploration of the effects of L ‐ and D ‐tetrahydroisoquinoline‐3‐carboxylic acid substitutions at positions 2,3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin
1995
·
Maurice Manning
, Ling Ling Cheng
, et al.
·
Journal of Peptide Science
·
18
Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors
1998
·
W Y Chan
, N C Wo
, et al.
·
British Journal of Pharmacology
·
16
PDF
Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids
1992
·
Maurice Manning
, Jozef Przybylski
, et al.
·
Journal of Medicinal Chemistry
·
14
Discovery and Design of Novel Vasopresses Hypotensive Pepitide Agonists
1999
·
M. Manning
, S. Stoev
, et al.
·
Journal of Receptors and Signal Transduction
·
12
Position 4 analogues of [deamino-Cys1] arginine vasopressin exhibit striking species differences for human and rat V2/V1b receptor selectivity
2005
·
Gilles Guillon
, Ana Pena
, et al.
·
Journal of Peptide Science
·
11
Synthesis and structure-activity investigation of novel vasopressin hypotensive peptide agonists
1999
·
Maurice Manning
, Stoytcho Stoev
, et al.
·
Journal of Peptide Science
·
11
Effects of a D-Cys6/L-Cys6 Interchange in Nonselective and Selective Vasopressin and Oxytocin Antagonists
1995
·
Maurice Manning
, Ling Ling Cheng
, et al.
·
Journal of Medicinal Chemistry
·
9
Invertebrate neuropeptides resembling vasotocin and some analogues: Synthesis and pharmacological properties
1990
·
M. Kruszyński
, M. Manning
, et al.
·
Cellular and Molecular Life Sciences
·
9
Novel selective hypotensive vasopressin peptides: cardiovascular and structure–activity-relationship studies
2001
·
W.Y Chan
, Roberto Levi
, et al.
·
European Journal of Pharmacology
·
7
Show more works
View as search
Works count:
37
Citation count:
796
H-index:
17
I10-index:
22
Year
Topic
Type
